The spread of the Coronavirus (COVID-19) has already presented serious threats to the healthcare industry. On March 30th, CMS announced a series of temporary regulatory waivers to better position the healthcare system for dealing with COVID-19. As part of this Interim Final Rule, CMS will modify the calculation of 2021 and 2022 Part C and D Star Ratings to combat the anticipated administrative and healthcare quality burdens in the coming years.
This whitepaper outlines CMS’ modifications to the 2021 and 2022 Part C and D Star Ratings and the potential impact to Medicare Advantage plan payments.
